Who
Antoinette Renee Leatherberry
Director
Company insider
Files Form 4 as: Director, Direct Digital Holdings; Director, Zoetis.
In numbers
- Trades disclosed
- 64
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $25K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 8 Dec 2020
- Last trade
- 12 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital Holdingsoption or derivative · Advertising & Marketing | SEC FORM 4 Code M | —37 at $0.00 | filing |
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Code M | —37 | filing |
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Sold | $6723 at $2.91 | filing |
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital Holdingsoption or derivative · Advertising & Marketing | SEC FORM 4 Code M | —37 at $0.00 | filing |
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Code M | —37 | filing |
| 12 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Sold | $6723 at $2.91 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Code M | —159 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Sold | $19867 at $2.96 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital Holdingsoption or derivative · Advertising & Marketing | SEC FORM 4 Code M | —159 at $0.00 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital Holdingsoption or derivative · Advertising & Marketing | SEC FORM 4 Code M | —159 at $0.00 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Code M | —159 | filing |
| 9 Jun 2026filed 29 Jun 2026 | Direct Digital HoldingsAdvertising & Marketing | SEC FORM 4 Sold | $19867 at $2.96 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,619 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code J | $52K406 at $127.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,619.333 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,619.33 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —1,619 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code J | $52K406 at $127.28 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,936 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —1,936 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.